PNC Financial Services Group Inc. Sells 4,013 Shares of HCA Healthcare, Inc. (NYSE:HCA)

PNC Financial Services Group Inc. cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 9.7% in the 4th quarter, Holdings Channel reports. The firm owned 37,483 shares of the company’s stock after selling 4,013 shares during the period. PNC Financial Services Group Inc.’s holdings in HCA Healthcare were worth $10,146,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of HCA. Syon Capital LLC bought a new stake in shares of HCA Healthcare during the third quarter worth $440,000. Capula Management Ltd acquired a new position in HCA Healthcare in the 3rd quarter worth about $487,000. Pinnacle Financial Partners Inc increased its stake in shares of HCA Healthcare by 2.0% in the third quarter. Pinnacle Financial Partners Inc now owns 279,332 shares of the company’s stock valued at $68,710,000 after buying an additional 5,474 shares during the period. Achmea Investment Management B.V. grew its holdings in HCA Healthcare by 13.7% during the 3rd quarter. Achmea Investment Management B.V. now owns 24,409 shares of the company’s stock worth $6,004,000 after acquiring an additional 2,938 shares during the last quarter. Finally, Paragon Advisors LLC lifted its holdings in shares of HCA Healthcare by 42.5% during the third quarter. Paragon Advisors LLC now owns 3,798 shares of the company’s stock worth $934,000 after purchasing an additional 1,132 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Ratings Changes

Several brokerages have commented on HCA. Wells Fargo & Company lifted their target price on HCA Healthcare from $303.00 to $315.00 and gave the stock an “equal weight” rating in a report on Thursday, March 28th. TD Cowen decreased their target price on shares of HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research report on Tuesday, April 30th. Royal Bank of Canada upped their price objective on shares of HCA Healthcare from $322.00 to $329.00 and gave the company an “outperform” rating in a research note on Monday, April 29th. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, May 18th. Finally, Oppenheimer boosted their price objective on HCA Healthcare from $330.00 to $345.00 and gave the company an “outperform” rating in a research note on Monday, April 29th. Four research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average target price of $317.00.

View Our Latest Report on HCA

Insider Activity at HCA Healthcare

In other news, SVP Chad J. Wasserman sold 876 shares of HCA Healthcare stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the sale, the senior vice president now directly owns 1,576 shares in the company, valued at approximately $520,474. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, SVP Kathryn A. Torres sold 1,863 shares of the business’s stock in a transaction dated Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total value of $607,673.34. Following the sale, the senior vice president now directly owns 19,612 shares in the company, valued at approximately $6,397,042.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Chad J. Wasserman sold 876 shares of HCA Healthcare stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the completion of the transaction, the senior vice president now owns 1,576 shares of the company’s stock, valued at approximately $520,474. The disclosure for this sale can be found here. Over the last three months, insiders sold 13,617 shares of company stock valued at $4,321,986. 1.70% of the stock is owned by insiders.

HCA Healthcare Trading Down 0.8 %

HCA opened at $318.55 on Thursday. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16 and a quick ratio of 1.02. The company’s 50-day moving average is $319.38 and its 200 day moving average is $304.51. The firm has a market capitalization of $83.43 billion, a PE ratio of 15.88, a P/E/G ratio of 1.49 and a beta of 1.66. HCA Healthcare, Inc. has a fifty-two week low of $215.96 and a fifty-two week high of $335.83.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its quarterly earnings results on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.01 by $0.35. The business had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. HCA Healthcare’s revenue was up 11.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $4.93 earnings per share. As a group, research analysts predict that HCA Healthcare, Inc. will post 20.84 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Friday, June 14th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.83%. HCA Healthcare’s payout ratio is presently 13.16%.

HCA Healthcare announced that its Board of Directors has initiated a share repurchase plan on Tuesday, January 30th that allows the company to buyback $6.00 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 7.4% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.